DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Huperzine-A is an investigational drug.
There have been 11 clinical trials for Huperzine-A. The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 2009.
The most common disease conditions in clinical trials are Alzheimer Disease, Cognition Disorders, and Schizophrenia. The leading clinical trial sponsors are Shandong Luye Pharmaceutical Co., Ltd., Alzheimer's Disease Cooperative Study (ADCS), and VA Nebraska Western Iowa Health Care System.
Recent Clinical Trials for Huperzine-A
|Clinical Study of Huperzine A in the Treatment of Patients With Hypertensive Cerebral Hemorrhage||Jiangsu Famous Medical Technology Co., Ltd.||Phase 4|
|Effects of Hearing Rehabilitative Interventions and Huperzine A on Presbycusis(Δ,kHz, dB,MMSE, AD)||Zhijun Bao||N/A|
|Early Diagnosis and Early Treatment of Alzheimer's Disease Based on Senile Plaque Imaging||Shanghai Mental Health Center||Phase 4|